The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
The Effectiveness of Pharmacist Interventions on Cardiovascular Risk
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M. (2001) · Clinical Science · doi:10.1042/cs20000335 · Cited by 1,084
Sex/Gender Differences in Cardiovascular Disease Prevention: What a Difference a Decade Makes
Mosca, L., Barrett-Connor, E., & Kass Wenger, N. (2011) · Circulation · doi:10.1161/circulationaha.110.968792 · Cited by 1,045
Okonofua, E. C., Simpson, K. N., Jesri, A., Rehman, S. U., Durkalski, V. L., & Egan, B. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000200702.76436.4b · Cited by 527
Smolderen, K. G., Bell, A., Lei, Y., Cohen, E. A., Gabriel Steg, P., Bhatt, D. L., & Mahoney, E. M. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)70437-2 · Cited by 57
Research works printed but not linked: 29
- 2011, Million hearts: strategies to reduce the prevalence of leading cardiovascular disease risk factors–United States, 2011, MMWR Morb Mortal Wkly Rep, 60, 1248
- Lim, 2012, A comparative assessment of burden of disease injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010, Lancet, 380, 2224, 10.1016/S0140-6736(12)61766-8 · DOI · Paper page
- Braga, 2010, Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada, Can J Cardiol, 26, 297
- Al Hamarneh, 2012, Glycemic control in community dwelling patients with type 2 diabetes, Can Pharm J, 145, 68, 10.3821/145.2.cpj68 · doi:10.3821/145.2.cpj68
- Ritchey, 2014, Million hearts: prevalence of leading cardiovascular disease risk factors–United States, 2005-2012, MMWR Morb Mortal Wkly Rep, 63, 462
- Leiter, 2013, Type 2 diabetes mellitus management in Canada: is it improving?, Can J Diabetes, 37, 82, 10.1016/j.jcjd.2013.02.055 · DOI
- Grover, 2011, The challenges and benefits of cardiovascular risk assessment in clinical practice, Can J Cardiol, 27, 481
- Shiu, 2006, Quantifying opportunities to affect diabetes management in the community, Can Pharm J, 139, 37
- Vivian, 2001, Improving blood pressure control in a pharmacist-managed hypertension clinic, Pharmacotherapy, 21, 1337, 10.1592/phco.21.17.1337.34424 · DOI
- Scott, 2006, Outcomes of pharmacist-managed diabetes care services in a community health centre, Am J Health-Syst Pharm, 63, 2116, 10.2146/ajhp060040 · DOI
- Santschi, 2011, Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials, Arch Intern Med, 171, 1441, 10.1001/archinternmed.2011.399 · DOI · Paper page
- Tsuyuki, 2002, A randomized trial of the effect of community pharmacist intervention on cholesterol risk management – the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP), Arch Intern Med, 162, 1149, 10.1001/archinte.162.10.1149 · DOI · Paper page
- McLean, 2008, A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus – Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN), Arch Intern Med, 168, 2355, 10.1001/archinte.168.21.2355 · DOI · Paper page
- Kassamali, 2011, Case finding: the missing link in chronic disease management, Can Pharm J, 144, 170, 10.3821/1913-701X-144.4.170 · doi:10.3821/1913-701x-144.4.170
- Daskalopoulou, 2015, The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension, Can J Cardiol, 31, 549
- Wilson, 2012, An international model to predict recurrent cardiovascular disease, Am J Med, 125, 695, 10.1016/j.amjmed.2012.01.014 · DOI · Paper page
- Grover, 2007, Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy. The CHECK-UP Study: a randomized controlled trial, Arch Intern Med, 167, 2296, 10.1001/archinte.167.21.2296 · DOI · Paper page
- 2013, KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease, Kidney Int Suppl, 3, 1
- 2013, Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada, Can J Diabetes, 37, S1
- Hackam, 2013, The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension, Can J Cardiol, 29, 528
- Genest, 2009, 2009 Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult–2009 recommendations, Can J Cardiol, 25, 567
- Anderson, 2013, 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult, Can J Cardiol, 29, 151
- Tobe, 2011, Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE initiative, CMAJ, 183, E1135, 10.1503/cmaj.101508 · DOI
- Al Hamarneh, 2013, Pharmacist intervention for glycaemic control in the community (the RxING study), BMJ Open, 3, 10.1136/bmjopen-2013-003154 · DOI
- Tsuyuki, 2015, Randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community: the Alberta clinical trial in optimizing hypertension (RxACTION), Circulation, 132, 93, 10.1161/CIRCULATIONAHA.115.015464 · DOI · Paper page
- O’Donovan, 2014, Pharmacist’s use of screening tools to estimate risk of CVD: a review of the literature, Pharmacy, 2, 27, 10.3390/pharmacy2010027 · DOI
- McNamara, 2010, Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the pharmacist assessment of adherence, risk and treatment of cardiovascular disease (PAART CVD) pilot study, BMC Health Serv Res, 10, 264, 10.1186/1472-6963-10-264 · DOI
- Al Hamarneh, 2016, Community pharmacists targeted screening for chronic kidney disease, Can Pharm J, 149, 13, 10.1177/1715163515618421 · doi:10.1177/1715163515618421
- Curtis, 2015, Online clinical pathway for managing adults with chronic kidney disease, Can Pharm J, 148, 257, 10.1177/1715163515597243 · DOI
Cited by
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000596 · Cited by 1,127
Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?
Mc Namara, K., Alzubaidi, H., & Jackson, J. K. (2019) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s133088 · Cited by 410
Pascucci, D., Sassano, M., Nurchis, M. C., Cicconi, M., Acampora, A., Park, D., Morano, C., & Damiani, G. (2021) · Health Policy · doi:10.1016/j.healthpol.2020.12.006 · Cited by 102
Metadata
- Authors
- Tsuyuki, R. T., Al Hamarneh, Y. N., Jones, C. A., & Hemmelgarn, B. R.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 67
- Issue
- 24
- Pages
- 2846-2854
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2469548291
- Cited by
- 209
- References
- 6
- FWCI
- 26.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 385 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effectiveness of Pharmacist Interventions on Cardiovascular Risk. https://app.cochat.ai/papers/10.1016/j.jacc.2016.03.528
- The paper
- Tsuyuki, R. T., Al Hamarneh, Y. N., Jones, C. A., & Hemmelgarn, B. R. (2016). The Effectiveness of Pharmacist Interventions on Cardiovascular Risk. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2016.03.528
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.